Immunome, Inc. (IMNM) Misses Q3 EPS by 24c

Immunome, Inc. (NASDAQ: IMNM) reported Q3 EPS of ($0.78), $0.24 worse than the analyst estimate of ($0.54).

For earnings history and earnings-related data on Immunome, Inc. (IMNM) click here.

You May Also Be Interested In

• BofA maintains underperform ratings on six BDC stocks
• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Wolfe Research sees CNH stock flat 2027 outlook on commodity prices